Related Experiment Video
Updated: May 7, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Optimizing insulin pump therapy: a quality improvement project
Lisa T Meade1,2, Wanda E Rushton1
1Department of Endocrinology, Piedmont HealthCare, Statesville, NC, USA (Dr Meade, Ms Rushton)
The Diabetes Educator
|September 19, 2013
Summary
This study assessed insulin pump use via a questionnaire, identifying common patient deficiencies. Targeted education can improve self-management and prevent adverse events in diabetes care.
Area of Science:
- Endocrinology
- Diabetes Management
- Medical Devices
Background:
- Insulin pump therapy is crucial for diabetes management.
- Ongoing assessment and education are vital for optimizing insulin pump use.
- Patient understanding of device operations and troubleshooting is essential.
Purpose of the Study:
- To evaluate current insulin pump usage patterns.
- To identify deficiencies in patient self-management of insulin pumps.
- To inform targeted educational interventions for insulin pump users.
Main Methods:
- A quality improvement project utilized a pump assessment questionnaire.
- Eighty-nine patients with type 1 and type 2 diabetes participated.
- A certified diabetes educator reviewed questionnaire responses with patients.
Main Results:
- Common deficiencies included issues with basal insulin prescriptions, site infection management, and sick day protocols.
- Patients demonstrated suboptimal use of advanced features like bolus calculators.
- Lack of readily available supplies (syringes, glucagon kits) was also noted.
Conclusions:
- Pump assessment questionnaires facilitate focused discussions on patient behaviors.
- Routine use of these questionnaires can enhance patient education.
- This approach may help prevent adverse events associated with insulin pump therapy.
Related Concept Videos
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:27Insulin Formulations: Types and Delivery
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...
Short-acting insulins are divided into rapid-acting...
01:25Insulin: Biosynthesis, Chemistry, and Preparation
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
01:24Dosage Regimen: Individualization
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...